Combination of SHP2, PI3K, and KRAS G12C inhibitors was found to induce durable tumor regression in EMT-induced mouse xenografts, which exhibit FGFR and IGF1R-induced MAPK and PI3K reactivation [44]. Here, PTPN11 is linked to neoplasm.